JPS6234760B2 - - Google Patents

Info

Publication number
JPS6234760B2
JPS6234760B2 JP58176091A JP17609183A JPS6234760B2 JP S6234760 B2 JPS6234760 B2 JP S6234760B2 JP 58176091 A JP58176091 A JP 58176091A JP 17609183 A JP17609183 A JP 17609183A JP S6234760 B2 JPS6234760 B2 JP S6234760B2
Authority
JP
Japan
Prior art keywords
ifn
arg
antibody
added
lys
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP58176091A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5980646A (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS5980646A publication Critical patent/JPS5980646A/ja
Publication of JPS6234760B2 publication Critical patent/JPS6234760B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/249—Interferons
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6866—Interferon
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP58176091A 1982-09-22 1983-09-22 ヒトγ型インタ−フェロンの精製法 Granted JPS5980646A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
PCT/JP1982/000381 WO1984001149A1 (fr) 1982-09-22 1982-09-22 Nouveau polypeptide et son utilisation
MC82/00444 1982-11-22
MC83/00174 1983-05-31
MC82/00381 1983-09-22

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP59052244A Division JPS6034994A (ja) 1982-09-22 1984-03-21 新規ポリペプチドおよびその用途

Publications (2)

Publication Number Publication Date
JPS5980646A JPS5980646A (ja) 1984-05-10
JPS6234760B2 true JPS6234760B2 (OSRAM) 1987-07-28

Family

ID=13762331

Family Applications (2)

Application Number Title Priority Date Filing Date
JP58176091A Granted JPS5980646A (ja) 1982-09-22 1983-09-22 ヒトγ型インタ−フェロンの精製法
JP59052244A Pending JPS6034994A (ja) 1982-09-22 1984-03-21 新規ポリペプチドおよびその用途

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP59052244A Pending JPS6034994A (ja) 1982-09-22 1984-03-21 新規ポリペプチドおよびその用途

Country Status (3)

Country Link
JP (2) JPS5980646A (OSRAM)
WO (1) WO1984001149A1 (OSRAM)
ZA (1) ZA837058B (OSRAM)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985004420A1 (fr) * 1984-03-29 1985-10-10 Takeda Chemical Industries, Ltd. Nouvel adn et son utilisation
JPH0653067B2 (ja) * 1984-09-11 1994-07-20 武田薬品工業株式会社 新規ハイブリドーマおよびその製造法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA814375B (en) * 1980-07-01 1982-07-28 Hoffmann La Roche Interferons and process for their preparation

Also Published As

Publication number Publication date
JPS5980646A (ja) 1984-05-10
WO1984001149A1 (fr) 1984-03-29
JPS6034994A (ja) 1985-02-22
ZA837058B (en) 1984-04-25

Similar Documents

Publication Publication Date Title
KR910001726B1 (ko) 펩티드의 제조방법
JPS6411639B2 (OSRAM)
JP2515308B2 (ja) ヒト免疫インタ−フエロン
JPH0736757B2 (ja) ハイブリドインターフェロン遺伝子
US5681720A (en) DNA encoding human granulocyte colony stimulating factor plasmids and host cells comprising same, and methods of expressing the encoded polypeptide
JPH083061A (ja) 腫瘍壊死因子含有組成物
EP0368486A2 (en) Novel inhibitors of platelet binding
JPH11505132A (ja) 非免疫原性ペプチドを介して結合されたインターフェロン―αと免疫グロブリンとのハイブリッド
HU196460B (en) Process for producing homogenous immune interferon fragment and pharmaceutical compositions comprising it
JP3784078B2 (ja) 可溶性ｌｄｌリセプター
JP2634132B2 (ja) 新規ペプチド
JPS6234760B2 (OSRAM)
US5420113A (en) [Leu13]motilin, DNAs coding for same and methods for producing same
EP0211321A2 (en) Amino-acid composition, method for its production and medical composition containing it
WO1984004745A1 (fr) Nouveaux polypeptides et leur utilisation
JPH0646959B2 (ja) 新規ポリペプチドおよびその用途
JPH0653067B2 (ja) 新規ハイブリドーマおよびその製造法
CA2030798A1 (en) Antimetastatic peptides
WO1984002130A1 (fr) Nouveaux polypeptides et leur utilisation